Aprogen Biologics Inc.

KOSE:A003060 Stok Raporu

Piyasa değeri: ₩165.8b

Aprogen Biologics Temettü

Temettü kriter kontrolleri 0/6

Aprogen Biologics does not have a record of paying a dividend.

Anahtar bilgiler

n/a

Temettü verimi

-33.6%

Geri Alım Getirisi

Toplam Hissedar Getirisi-33.6%
Gelecekteki Temettü Verimin/a
Temettü Büyümesin/a
Bir sonraki temettü ödeme tarihin/a
Eski temettü tarihin/a
Hisse başına temettün/a
Ödeme oranın/a

Son temettü güncellemeleri

Güncelleme yok

Recent updates

Risks Still Elevated At These Prices As Aprogen Biologics Inc. (KRX:003060) Shares Dive 26%

Jun 20
Risks Still Elevated At These Prices As Aprogen Biologics Inc. (KRX:003060) Shares Dive 26%

More Unpleasant Surprises Could Be In Store For Aprogen Biologics Inc.'s (KRX:003060) Shares After Tumbling 28%

Apr 18
More Unpleasant Surprises Could Be In Store For Aprogen Biologics Inc.'s (KRX:003060) Shares After Tumbling 28%

We Wouldn't Rely On Aprogen pharmaceuticalsInc's (KRX:003060) Statutory Earnings As A Guide

Jan 16
We Wouldn't Rely On Aprogen pharmaceuticalsInc's (KRX:003060) Statutory Earnings As A Guide

Aprogen pharmaceuticals,Inc.'s (KRX:003060) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Dec 20
Aprogen pharmaceuticals,Inc.'s (KRX:003060) Financials Are Too Obscure To Link With Current Share Price Momentum: What's In Store For the Stock?

Is Aprogen pharmaceuticalsInc (KRX:003060) A Risky Investment?

Nov 24
Is Aprogen pharmaceuticalsInc (KRX:003060) A Risky Investment?

Ödemelerde İstikrar ve Büyüme

Temettü verilerini getirme

İstikrarlı Temettü: Insufficient data to determine if A003060's dividends per share have been stable in the past.

Büyüyen Temettü: Insufficient data to determine if A003060's dividend payments have been increasing.


Piyasaya Karşı Temettü Getirisi

Aprogen Biologics Piyasaya Karşı Temettü Getirisi
A003060 temettü verimi piyasa ile karşılaştırıldığında nasıldır?
SegmentTemettü Verimi
Şirket (A003060)n/a
Pazarın Alt %25'i (KR)1.2%
Pazarın En İyi %25'i (KR)3.8%
Sektör Ortalaması (Pharmaceuticals)1.0%
Analist tahmini (A003060) (3 yıla kadar)n/a

Önemli Temettü: Unable to evaluate A003060's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

Yüksek Temettü: Unable to evaluate A003060's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Hissedarlara Ödenen Kazanç

Kazanç Kapsamı: Insufficient data to calculate A003060's payout ratio to determine if its dividend payments are covered by earnings.


Hissedarlara Nakit Ödeme

Nakit Akışı Kapsamı: Unable to calculate sustainability of dividends as A003060 has not reported any payouts.


Güçlü temettü ödeyen şirketleri keşfedin